Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T79793 |
CRF1 receptor antagonist-1
|
CFTR | Membrane transporter/Ion channel |
CRF1 receptor antagonist-1 (Compound 2)为CRF1受体拮抗剂,适用于先天性肾上腺增生症(CAH)的研究领域。 | |||
T7361 |
Verucerfont
NBI77860,3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-恶二唑-5-基)丙基]吡唑并[1,5-A]嘧啶-7-胺,GSK561679 |
CRFR | GPCR/G Protein |
Verucerfont (NBI77860) 是促肾上腺皮质激素释放因子受体 1 (CRF1) 拮抗剂,作用于 CRF1(IC50:6.1 nM),CRF2 (IC50>1000 nM)和 CRF-BP (IC50>1000 nM)。 | |||
T16713 |
R121919
NBI30775 |
Others | Others |
R121919 (NBI30775) 是一种高效的促肾上腺皮质激素释放因子受体 1 (CRF1)小分子受体拮抗剂,具有抗抑郁和抗焦虑活性,抑制 CRF1 受体、 CRF2 受体和 CRF 结合蛋白。 | |||
T4329 |
CP 376395
CP-316311 |
CRFR | GPCR/G Protein |
CP 376395 (CP-316311)是一种 CRF1受体选择性拮抗剂。 | |||
T31095 |
Crinecerfont
SSR125543,SSR 125543,SSR-125543,SSR125543A,SSR 125543A,SSR-125543A |
CRFR | GPCR/G Protein |
Crinecerfont (SSR-125543) 是促肾上腺皮质激素释放因子 1 受体 (CRF1) 的特异性拮抗剂,可用于经典先天性肾上腺增生的研究。 | |||
T12276 |
NVS-CRF38
|
Others | Others |
NVS-CRF38 is an antagonist of corticotropin-releasing factor receptor 1 (CRF1). | |||
T23067 |
NGD 98-2 hydrochloride
|
Others | Others |
corticotropin-releasing factor receptor 1 (CRF1) antagonist | |||
T33607 |
NBI-34041
NBI34041,SB 723620,SB-723620,SB723620 |
||
NBI-34041 is an effective and high-affinity CRF1 receptor antagonist that effectively reduces endocrine responses to CRF(1) receptor-mediated pharmacological and behavioral challenges. | |||
T26855 |
BMS-665053
BMS665053 |
||
BMS-665053 is a corticotropin-releasing factor-1 (CRF1) receptor antagonist (IC50 = 1.0 nM). BMS-665053)11 is a potent inhibitor of CRF-stimulated cyclic adenosine monophosphate (cAMP) production in human Y-79 retinoblastoma cells (IC50 = 4.9 nM). In addi | |||
T75891 |
α-Helical CRF(9-41) TFA
|
||
α-Helical CRF(9-41) TFA 是一种竞争性 CRF2受体拮抗剂,KB 约为 100 nM。α-Helical CRF(9-41) TFA 也是一种 CRF1受体的部分激动剂,EC50为 140 nM。 | |||
TP2091 |
Antisauvagine-30
|
||
Potent, selective and competitive corticotropin-releasing factor CRF2 receptor antagonist (Kd values are 1.4 and 153.6 nM for binding to mouse CRF2β and rat CRF1 receptors respectively). Inhibits sauvagine-stimulated cAMP accumulation in HEK-mCRF2β cells | |||
T38228 |
R 121919 hydrochloride
|
||
High affinity corticotropin releasing factor receptor1 (CRF1) antagonist (Ki = 3.5 nM). Reduces stress-induced elevations of plasma ACTH. Anxiolytic and antidepressant in vivo. Orally bioavailable. Chen and Grigoriadis (2005) NBI 30775 (R121919), an orally active antagonist of the corticotropin-releasing factor (CRF) type-1 receptor for the treatment of anxiety and depression. Drug Dev.Res. 65 216 |Jutkiewicz et al (2005) The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919... | |||
T75804 |
K41498 TFA
|
||
K41498 TFA 是一种强选择性的CRF2 receptor 拮抗剂,其对人 CRF2α、CRF2β和 CRF1受体的Ki 值分别为 0.66 nM、0.62 nM 和425 nM。K41498 TFA 是 antisauvagine-30 (aSvg-30) 的类似物,可抑制 sauvagine 刺激的 cAMP 在 hCRF2α/hCRF2β表达细胞中的积累。K41498 可用于低血压研究。 |